FTSE All-Share
4.991,49
PKT
+5,15
PKT
+0,10
%
Werbung
Analysen zu FTSE All-Share-Werten
Datum | Rating | Analyst | |
---|---|---|---|
07.01.19 | Shell (ex Royal Dutch Shell) buy | Goldman Sachs Group Inc. | |
04.01.19 | Rio Tinto buy | UBS AG | |
04.01.19 | BP buy | UBS AG | |
04.01.19 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
04.01.19 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
04.01.19 | Glencore Neutral | UBS AG | |
04.01.19 | Diageo Underperform | Bernstein Research | |
04.01.19 | BP kaufen | RBC Capital Markets | |
04.01.19 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
02.01.19 | GSK buy | UBS AG | |
02.01.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
20.12.18 | National Grid Neutral | Credit Suisse Group | |
20.12.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
20.12.18 | Lloyds Banking Group Outperform | RBC Capital Markets | |
20.12.18 | HSBC Underperform | RBC Capital Markets | |
20.12.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
20.12.18 | Lloyds Banking Group Sell | Goldman Sachs Group Inc. | |
20.12.18 | GSK Hold | Deutsche Bank AG | |
19.12.18 | GSK buy | Goldman Sachs Group Inc. | |
19.12.18 | BP Outperform | Credit Suisse Group | |
19.12.18 | Shell (ex Royal Dutch Shell) Outperform | Credit Suisse Group | |
18.12.18 | BAT overweight | Barclays Capital | |
18.12.18 | BAT Outperform | Credit Suisse Group | |
18.12.18 | Vodafone Group buy | Deutsche Bank AG | |
17.12.18 | GSK Neutral | Credit Suisse Group | |
17.12.18 | Glencore Outperform | Credit Suisse Group | |
17.12.18 | Unilever Neutral | Goldman Sachs Group Inc. | |
17.12.18 | Unilever Neutral | Goldman Sachs Group Inc. | |
17.12.18 | Vodafone Group overweight | Barclays Capital | |
17.12.18 | Diageo buy | Goldman Sachs Group Inc. | |
14.12.18 | Rio Tinto Neutral | Credit Suisse Group | |
14.12.18 | GSK Underweight | Morgan Stanley | |
14.12.18 | AstraZeneca Equal-Weight | Morgan Stanley | |
14.12.18 | GSK Neutral | Merrill Lynch & Co., Inc. | |
14.12.18 | Vodafone Group Outperform | RBC Capital Markets | |
14.12.18 | AstraZeneca buy | Merrill Lynch & Co., Inc. | |
14.12.18 | BP Conviction Buy List | Goldman Sachs Group Inc. | |
14.12.18 | Shell (ex Royal Dutch Shell) buy | Goldman Sachs Group Inc. | |
13.12.18 | BAT overweight | JP Morgan Chase & Co. | |
13.12.18 | BAT buy | Deutsche Bank AG |